Table 1 Demographic, anthropometric, clinical and laboratory characterization of study population
Men (n = 3,087) | Women (n = 3,373) | P -value | ||||
|---|---|---|---|---|---|---|
Mean | s.d | Mean | s.d | |||
Age (y) | Age (y) | |||||
Age < 45 | 30.47 | 8.56 | Age < 45 | 31.01 | 8.34 | 0.051 |
45≦Age < 60 | 50.87 | 4.14 | 45≦Age < 60 | 51.05 | 4.16 | 0.372 |
Age≧60 | 69.93 | 4.9 | Age≧60 | 69.38 | 7.32 | 0.167 |
WHR | WHR | |||||
WHR < 0.84 | 0.80 | 0.06 | WHR < 0.75 | 0.71 | 0.04 | <0.0001 |
0.84≦WHR < 0.90 | 0.87 | 0.02 | 0.75≦WHR < 0.81 | 0.78 | 0.02 | <0.0001 |
WHR≧0.90 | 0.94 | 0.05 | WHR≧0.81 | 0.87 | 0.05 | <0.0001 |
HDL-C (mg/dL) | HDL-C (mg/dL) | |||||
HDL-C < 44 | 34.89 | 6.35 | HDL-C < 52 | 43.25 | 6.67 | <0.0001 |
44≦HDL-C < 56 | 49.47 | 3.42 | 52≦HDL-C < 64 | 57.26 | 3.42 | <0.0001 |
HDL-C≧56 | 66.49 | 9.83 | HDL-C≧64 | 74.07 | 9.21 | <0.0001 |
LDL-C (mg/dL) | LDL-C (mg/dL) | |||||
LDL-C < 103 | 87.81 | 10.94 | LDL-C < 100 | 86.39 | 9.27 | 0.001 |
103≦LDL-C < 124 | 113.07 | 6.14 | 100≦LDL-C < 122 | 110.09 | 6.41 | <0.0001 |
LDL-C≧124 | 144.88 | 19.34 | LDL-C≧122 | 143.57 | 20.36 | 0.116 |
ApoA1 (mg/dL) | ApoA1 (mg/dL) | |||||
ApoA1 < 126 | 114.24 | 9.25 | ApoA1 < 139 | 126.64 | 10.33 | <0.0001 |
126≦ApoA1 < 143 | 133.37 | 4.76 | 139≦ApoA1 < 158 | 147.69 | 5.29 | <0.0001 |
ApoA1≧143 | 161.73 | 17.76 | ApoA1≧158 | 177.71 | 18.61 | <0.0001 |
ApoB (mg/dL) | ApoB (mg/dL) | |||||
ApoB < 79 | 64.62 | 10.25 | ApoB <72 | 60.43 | 8.19 | <0.0001 |
79≦ApoB < 101 | 89.38 | 6.22 | 72≦ApoB < 93 | 81.38 | 5.93 | <0.0001 |
ApoB≧101 | 119.00 | 16.76 | ApoB≧93 | 113.16 | 18.76 | <0.0001 |
SBP (mmHg) | 119.03 | 16.40 | SBP (mmHg) | 112.52 | 18.95 | <0.0001 |
DBP (mmHg) | 77.70 | 10.98 | DBP (mmHg) | 72.30 | 10.88 | <0.0001 |
FPG (mg/dL) | 94.76 | 28.68 | FPG (mg/dL) | 93.82 | 28.25 | 0.206 |
HbA1c (%) | 5.37 | 1.03 | HbA1c (%) | 5.34 | 1.05 | 0.154 |
Uric acid (mg/dL) | 7.23 | 1.67 | UA (mg/dL) | 5.55 | 1.51 | <0.0001 |
Creatinine (mg/dL) | 1.03 | 0.28 | CREA (mg/dL) | 0.80 | 0.32 | <0.0001 |